Gilead’s Kite to acquire CAR T-therapies developer Tmunity Therapeutics

Kite, an arm of Gilead Sciences, has agreed to acquire Tmunity Therapeutics, a Philadelphia-based clinical-stage biotech company focused on next-generation CAR T-therapies and technologies, for ... Read More